Genprex Inc
Change company Symbol lookup
Select an option...
GNPX Genprex Inc
CHHL China Holdings Inc
DARE Dare Bioscience Inc
HEXEY Hellenic Exchanges Athens Stock Exchange SA
CLWA Fuzebox Software Corp
NGHC National General Holdings Corp
IVR Invesco Mortgage Capital Inc
CXP Columbia Property Trust Inc
TYTMF Tokyo Tatemono Co Ltd
ARPTF Airport City Ltd
Go

Health Care : Biotechnology |
Company profile

Genprex, Inc. is a clinical stage gene therapy company. The Company is focused on developing cancer-based upon its novel proprietary technology platform, including its initial product candidate, Oncoprex, immunogene therapy, or Oncoprex. The Company’s Oncoprex is lead product candidate, is the subject of an ongoing Phase I/II clinical trials at The University of Texas MD Anderson Cancer Center in patients with late stage non-small cell lung cancer, or NSCLC. Oncoprex gene therapy platform may also be effective with respect to other types of cancer, including breast, head and neck, renal cell (kidney), soft tissue cancer. The Company’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles. The Company’s Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis.

Closing Price
$4.28
Day's Change
1.54 (56.20%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.75
Day's Low
3.15
Volume
(Heavy Day)
Volume:
83,976,853

10-day average volume:
13,833,708
83,976,853

Upcoming Events

There are no upcoming events for GNPX

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
August 13, 2019Q2 2019 Earnings Release-$0.24-$0.21 to -$0.21--
May 15, 2019Q1 2019 Earnings Release-$0.14-$0.23 to -$0.17--
April 1, 2019Q4 2018 Earnings Release-$0.23-$0.15 to -$0.12--

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.